Chris Markoch, Editor & Contributing Author at MarketBeat Articles by Chris Markoch - Page 7November 5, 2024 11:21 AM ETPalantir Cracks $50, Is There Still Time to Get on Board? Chris MarkochPalantir stock is up over $50 after a strong earnings report, but investors should expect more volatility as analysts and institutions decide how to proceedNYSE:PLTRNASDAQ:NVDARead Palantir Cracks $50, Is There Still Time to Get on Board? November 5, 2024 7:39 AM ETNVIDIA, Sherwin-Williams Join the Dow: What Investors Should KnowChris MarkochNVIDIA and Sherwin-Williams will join the DJIA on November 8, but investors shouldn't view this inclusion as a catalyst for owning each stockNASDAQ:NVDANYSE:SHWNASDAQ:INTCRead NVIDIA, Sherwin-Williams Join the Dow: What Investors Should KnowNovember 5, 2024 5:00 AM ETMerck vs. Bristol-Myers: Analyst Views Differ After Q3 EarningsChris MarkochAfter strong earnings reports, Merck may be a better choice than Bristol-Meyers in the short term - but both may present a challenge for buy-and-hold investors.NYSE:MRKNYSE:BMYNYSE:ABBVRead Merck vs. Bristol-Myers: Analyst Views Differ After Q3 EarningsNovember 4, 2024 6:09 AM ET3 Stocks Under $20 With Strong-Buy RatingsChris MarkochAt under $20 a share, these stocks have multiple Strong Buy ratings which gives risk-tolerant investors an opportunity for significant profitsOTCMKTS:PROSYOTCMKTS:NTDOYNYSE:GOLDRead 3 Stocks Under $20 With Strong-Buy RatingsNovember 1, 2024 6:19 AM ETApple Earnings - When Really Good Just Isn’t Good Enough Chris MarkochApple stock is down after the company delivered a good earnings report that wasn’t good enough for analysts who had expectations of greatnessNASDAQ:AAPLRead Apple Earnings - When Really Good Just Isn’t Good Enough October 31, 2024 5:00 AM ETViking Therapeutics Stock: A Pre-Election Bet Worth ConsideringChris MarkochViking Therapeutics is making headway in the weight loss drug market; but even though the payoff is years away, there's still plenty of upside for investorsNASDAQ:VKTXNYSE:NVONYSE:LLYRead Viking Therapeutics Stock: A Pre-Election Bet Worth ConsideringOctober 30, 2024 7:30 AM ETCan Evolv Stock Recover From Its Massive Self-Inflicted Drop?Chris MarkochEVLV stock is down approximately 40% after acknowledging accounting irregularities based on premature or incorrectly recorded revenueNASDAQ:EVLVRead Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?October 26, 2024 6:00 AM ETLam Research Proves Analysts Wrong with a Strong Earnings ReportChris MarkochLam Research stock is up more than 4% after a solid earnings report, but with analyst sentiment still bearish investors may still wonder if its time to buy NASDAQ:LRCXRead Lam Research Proves Analysts Wrong with a Strong Earnings ReportOctober 23, 2024 6:30 AM ETShort Sellers Eye Palantir: Should You Buy the Dip?Chris MarkochA spike in short interest combined with significant volume suggests PLTR stock may move lower, but until earnings both bulls and bears will be disappointedNYSE:PLTRRead Short Sellers Eye Palantir: Should You Buy the Dip?October 21, 2024 5:30 AM ETOversold But Ready to Rally: 5 Stocks to Watch NowChris MarkochThese stocks are or were oversold based on the RSI index, but future catalysts suggest that these stocks may be or are already starting, a bullish reversalNASDAQ:TSLANYSE:UNHNYSE:GISRead Oversold But Ready to Rally: 5 Stocks to Watch NowOctober 17, 2024 6:15 AM ETWhy Buffett Loves Occidental Stock And What It Means for ChevronChris MarkochBerkshire Hathway continues to buy shares of Occidental Petroleum and sell shares of Chevron, but investors should be careful not to draw the wrong conclusionNYSE:OXYNYSE:BRK.BNYSE:CVXRead Why Buffett Loves Occidental Stock And What It Means for ChevronOctober 16, 2024 6:00 AM ET3 Election Momentum Stocks You Might Have MissedChris MarkochElections have a way of providing clarity for investors; here are three picks for stocks that are carrying momentum into the electionNASDAQ:COSTNASDAQ:MSFTNYSE:CCJRead 3 Election Momentum Stocks You Might Have MissedOctober 16, 2024 5:15 AM ETNVIDIA Stock Continues to Be Wall Street’s Favorite: Here's WhyChris MarkochNVDA stock recently hit a new 52-week high as at least one analyst believes demand for its GPUs will remain resilient despite the delay of its Blackwell chipNASDAQ:NVDANASDAQ:AMDNYSE:GSRead NVIDIA Stock Continues to Be Wall Street’s Favorite: Here's WhyOctober 14, 2024 7:12 AM ETCaterpillar and Deere Get Analyst Upgrades, Could Move HigherChris MarkochCaterpillar and Deere & Co. were trading near a 52-week high before receiving price target upgrades; investors may wonder if this is a buying opportunityNYSE:CATNYSE:DENYSE:CRead Caterpillar and Deere Get Analyst Upgrades, Could Move HigherOctober 12, 2024 5:15 AM ET3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideChris MarkochThese three undervalued mid-cap stocks combine a price below $20 and heavy insider buying; that's a formula for impressive gainsNYSE:RIGNYSE:CRGYNASDAQ:MBLYRead 3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideOctober 11, 2024 5:15 AM ETVolatility in Applied Digital May Create an Entry OpportunityChris MarkochApplied Digital stock is showing volatile price action after a positive earnings report but this may create an opportunity for patient investorsNASDAQ:APLDNASDAQ:NVDARead Volatility in Applied Digital May Create an Entry OpportunityOctober 10, 2024 6:54 AM ETAt $43 Is It Time to Take Profit With Palantir?Chris MarkochWith Palantir stock above $43 a share, traders are asking if now is a time to take some profits; here's what you should know before making a decisionNYSE:PLTRNASDAQ:NVDARead At $43 Is It Time to Take Profit With Palantir?October 9, 2024 5:30 AM ETThese 3 Stocks Just Spiked—Buy the Rally or Sell the News?Chris MarkochInvestors received news about three stocks that moved each stock higher, but now investors have to decide whether to buy the rally or take some profitsNYSE:PFENYSE:ALTMNYSE:RIORead These 3 Stocks Just Spiked—Buy the Rally or Sell the News?October 7, 2024 5:00 AM ET3 Undervalued Dividend Stocks Primed for Growth in 2025Chris MarkochThese quality dividend stocks look significantly undervalued which gives you an opportunity to pair a high-yield dividend with strong capital appreciationNYSE:CVXNYSE:HESNASDAQ:PEPRead 3 Undervalued Dividend Stocks Primed for Growth in 2025October 5, 2024 5:15 AM ET3 Small-Cap Stocks on the Way to Bigger and Better DaysChris MarkochBorrowing conditions should improve for small-cap stocks, particularly those that already show solid fundamentals like the stocks mentioned hereNASDAQ:SBLKNASDAQ:EVLVNASDAQ:CENTARead 3 Small-Cap Stocks on the Way to Bigger and Better DaysOctober 4, 2024 6:42 AM ETChevron-Hess Merger Approved: Should You Buy Before Earnings?Chris MarkochAfter the FTC approval of its merger with Hess, Chevron stock may look attractive to value-hunting investors prior to the company’s earnings reportNYSE:CVXNYSE:HESNYSE:XOMRead Chevron-Hess Merger Approved: Should You Buy Before Earnings?October 2, 2024 10:46 AM ETS&P 500 Hitting Resistance: These 3 Stocks Offer the Best UpsideChris MarkochIf you’re investing in individual stocks a choppy S&P 500 is an opportunity to look for stocks with strong fundamentals that are being overlooked by investorsNYSEARCA:SPYNYSE:SLBNYSE:ALBRead S&P 500 Hitting Resistance: These 3 Stocks Offer the Best UpsideSeptember 30, 2024 7:46 AM ETEarnings Season Countdown: 4 Stocks Poised for GrowthChris MarkochEarnings growth is the single-best predictor of stock price growth; here are four names that investors should watch closely when they report earningsNASDAQ:AMZNNYSE:PSTGNASDAQ:NVDARead Earnings Season Countdown: 4 Stocks Poised for GrowthSeptember 26, 2024 9:50 AM ETRocket Lab Stock Soars: Should Investors Chase the Rally?Chris MarkochRocket Lab stock recently made a 52-week high after another successful launch, but RKLB stock is trading well above analyst estimates and is still unprofitableNASDAQ:RKLBRead Rocket Lab Stock Soars: Should Investors Chase the Rally? Page 7 of 37 « Most Recent‹ More Recent45678910 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
